Cohabiting with Smokers Is an Independent Factor for Worsening Arterial Stiffness Even in Smoking Workers

Atsushi Inomoto1, Junko Deguchi2, Rika Fukuda2

  • 1Faculty of Rehabilitation, Kyushu Nutrition Welfare University, Japan.

Journal of UOEH
|September 4, 2020
PubMed

Insights

Secondhand smoke exposure, particularly from living with smokers, significantly increases arterial stiffness (baPWV). Quitting smoking is essential for preventing cardiovascular disease progression in both smokers and their housemates.

Area of Science:

  • Cardiovascular Health
  • Public Health
  • Arteriosclerosis Research

Background:

  • Cardiovascular disease (CVD) prevention is a major public health concern.
  • Brachial-ankle pulse wave velocity (baPWV) is an indicator of arterial stiffness and CVD risk.
  • Previous studies on smoking's impact on baPWV have yielded inconsistent results.

Purpose of the Study:

  • To investigate the influence of smoking, including secondhand smoke (SHS), on arteriosclerosis.
  • To assess the relationship between SHS exposure and baPWV.
  • To develop strategies for preventing arteriosclerosis worsening.

Main Methods:

  • Recruited 295 male employees with various smoking exposures (smokers, living with smokers, SHS exposure).
  • Measured body composition and hemodynamics, including blood pressure and baPWV.
  • Utilized multiple regression analysis to identify factors associated with baPWV.

Main Results:

  • baPWV positively correlated with age, smoking index, alcohol consumption, body fat, blood pressure, and heart rate.
  • baPWV showed adverse effects in participants with metabolic syndrome (MetS) risk factors.
  • Cohabitation with smokers significantly increased baPWV, irrespective of an individual's smoking status.

Conclusions:

  • Exposure to tobacco smoke from cohabiting smokers elevates baPWV.
  • Reducing baPWV requires smokers to quit to protect both themselves and household members.
  • This highlights the critical impact of SHS on cardiovascular health.

Related Concept Videos

Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
161
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.9K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
721
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
226
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.6K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.0K